Kanabo Group (KNB) Competitors GBX 0.22 0.00 (0.00%) As of 08/14/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsBuy This Stock KNB vs. TLY, SPI, MGP, SBI, ODX, CIZ, HEMO, BNR, EVG, and MTFBShould you be buying Kanabo Group stock or one of its competitors? The main competitors of Kanabo Group include Totally (TLY), Spire Healthcare Group (SPI), Medica Group (MGP), Sourcebio International (SBI), Omega Diagnostics Group (ODX), Cizzle Biotechnology (CIZ), Hemogenyx Pharmaceuticals (HEMO), Burning Rock Biotech (BNR), Evgen Pharma (EVG), and Motif Bio (MTFB). These companies are all part of the "medical" sector. Kanabo Group vs. Its Competitors Totally Spire Healthcare Group Medica Group Sourcebio International Omega Diagnostics Group Cizzle Biotechnology Hemogenyx Pharmaceuticals Burning Rock Biotech Evgen Pharma Motif Bio Totally (LON:TLY) and Kanabo Group (LON:KNB) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, dividends, institutional ownership, risk, valuation, media sentiment, earnings and analyst recommendations. Which has better valuation & earnings, TLY or KNB? Totally has higher revenue and earnings than Kanabo Group. Kanabo Group is trading at a lower price-to-earnings ratio than Totally, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTotally£133.05M0.00-£3.79M-£1.93-0.13Kanabo Group£1.14M1.25-£8.18M-£1.29-0.17 Is TLY or KNB more profitable? Totally has a net margin of -2.85% compared to Kanabo Group's net margin of -717.63%. Totally's return on equity of -11.01% beat Kanabo Group's return on equity.Company Net Margins Return on Equity Return on Assets Totally-2.85% -11.01% -2.42% Kanabo Group -717.63%-121.77%-20.89% Do analysts prefer TLY or KNB? Totally presently has a consensus target price of GBX 20, indicating a potential upside of 7,900.00%. Given Totally's stronger consensus rating and higher probable upside, equities analysts clearly believe Totally is more favorable than Kanabo Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Totally 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Kanabo Group 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Do institutionals & insiders believe in TLY or KNB? 51.3% of Totally shares are held by institutional investors. Comparatively, 3.8% of Kanabo Group shares are held by institutional investors. 13.3% of Totally shares are held by insiders. Comparatively, 37.0% of Kanabo Group shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Which has more volatility & risk, TLY or KNB? Totally has a beta of 0.55, meaning that its share price is 45% less volatile than the S&P 500. Comparatively, Kanabo Group has a beta of 3.04, meaning that its share price is 204% more volatile than the S&P 500. Does the media prefer TLY or KNB? In the previous week, Totally had 4 more articles in the media than Kanabo Group. MarketBeat recorded 4 mentions for Totally and 0 mentions for Kanabo Group. Kanabo Group's average media sentiment score of 0.00 beat Totally's score of -0.18 indicating that Kanabo Group is being referred to more favorably in the news media. Company Overall Sentiment Totally Neutral Kanabo Group Neutral SummaryTotally beats Kanabo Group on 11 of the 16 factors compared between the two stocks. Get Kanabo Group News Delivered to You Automatically Sign up to receive the latest news and ratings for KNB and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding KNB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart KNB vs. The Competition Export to ExcelMetricKanabo GroupMedical Care Facilities IndustryMedical SectorLON ExchangeMarket Cap£1.42M£1.46B£5.70B£3.08BDividend YieldN/A4.04%3.77%5.04%P/E Ratio-0.176.9130.86171.50Price / Sales1.2514.05403.88290,516.98Price / Cash1.8212.3225.2227.94Price / Book0.241.929.515.58Net Income-£8.18M£58.06M£3.26B£5.89B7 Day PerformanceN/A3.02%4.50%0.23%1 Month PerformanceN/A4.34%5.22%0.43%1 Year Performance-80.43%32.39%31.92%72.36% Kanabo Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)KNBKanabo GroupN/AGBX 0.23flatN/AN/A£1.42M£1.14M-0.1720TLYTotally2.689 of 5 starsGBX 0.25+4.2%GBX 20+7,900.0%-97.5%£491K£133.05M-0.131,668Gap DownSPISpire Healthcare Group2.2347 of 5 starsGBX 214.50+0.7%GBX 294.33+37.2%-13.3%£861.37M£1.44B30.53420MGPMedica GroupN/AN/AN/AN/A£259.85M£76.98M3,516.671,212SBISourcebio InternationalN/AN/AN/AN/A£85.31M£75.61M1,277.78194Gap UpHigh Trading VolumeODXOmega Diagnostics GroupN/AN/AN/AN/A£5.23M£7.55M-220.0091Gap DownCIZCizzle BiotechnologyN/AGBX 1.33-5.3%N/A-16.4%£5.23MN/A-1,850.404News CoverageHigh Trading VolumeHEMOHemogenyx PharmaceuticalsN/AGBX 144.23+1.6%N/A+10,781.3%£5.14MN/A-737.8114Gap UpBNRBurning Rock BiotechN/AN/AN/AN/A£3.77MN/A0.001,390Gap DownHigh Trading VolumeEVGEvgen PharmaN/AN/AN/AN/A£3.42MN/A-80.0010MTFBMotif BioN/AN/AN/AN/A£3.28MN/A-0.036 Related Companies and Tools Related Companies Totally Alternatives Spire Healthcare Group Alternatives Medica Group Alternatives Sourcebio International Alternatives Omega Diagnostics Group Alternatives Cizzle Biotechnology Alternatives Hemogenyx Pharmaceuticals Alternatives Burning Rock Biotech Alternatives Evgen Pharma Alternatives Motif Bio Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:KNB) was last updated on 8/18/2025 by MarketBeat.com Staff From Our PartnersWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredThe stealth altcoin the financial world is underestimatingThis DeFi project could soar next When altcoin season fully kicks in—which the data suggests is happening R...Crypto 101 Media | SponsoredNew law could create $3.7 trillion tsunami.During a meeting in Washington D.C., Jeff Brown discovered a bold initiative. He calls it “President Trump’...Brownstone Research | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredBut this $20 American company could control the secretThe "Impossible" Chip That Runs on Pure Light Google's quantum computer shocked the world... but China DEMO...The Oxford Club | SponsoredTax Drain Deadline: Protect Your Wealth Before September 15thOn September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredElon Musk’s New TechnologyElon Musk is building something in Memphis that could eclipse even Tesla and SpaceX. At the heart of it is a n...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kanabo Group Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Kanabo Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access